Aspirin 162 mg

DRUG8 trials

Sponsors

Vanderbilt University, Aswan University Hospital, The University of Texas Health Science Center, Houston, Methodist Medical Center of Illinois, Johns Hopkins University

Conditions

Gestational HypertensionHealthyHypertension in PregnancyHypertensive Disorders of PregnancyObesityPre-EclampsiaPreeclampsiaPregnancy Loss

Phase 2

Effectiveness of Higher Aspirin Dosing for Prevention of Preeclampsia in High Risk Obese Gravida

CompletedNCT03961360

The University of Texas Health Science Center, HoustonHypertension in Pregnancy, Obesity, Pre-Eclampsia

Start: 2019-05-06End: 2023-04-10Updated: 2024-05-08

Phase 3

Trial to Determine Effective Aspirin Dose in COPD

RecruitingNCT05265299

Johns Hopkins UniversityPulmonary Disease, Chronic Obstructive

Start: 2023-05-16End: 2026-12-01Target: 48Updated: 2026-03-16

APPLE: Aspirin to Prevent Pregnancy Loss and Preeclampsia

RecruitingNCT06408181

University of PennsylvaniaPre-Eclampsia, Pregnancy Loss

Start: 2024-06-12End: 2029-06-01Target: 1150Updated: 2026-01-20

Phase 4

162 mg of Aspirin for Prevention of Preeclampsia

Methodist Medical Center of IllinoisPreeclampsia

Start: 2021-07-06End: 2022-06-09Target: 200Updated: 2022-02-02

Effectiveness of Two Aspirin Doses for Prevention of Hypertensive Disorders of Pregnancy: ASPIRIN TRIAL

RecruitingNCT06468202

Ohio State UniversityGestational Hypertension, Hypertensive Disorders of Pregnancy, Preeclampsia

Start: 2024-10-18End: 2030-02-01Target: 10742Updated: 2025-12-24

Unknown Phase

Comparative Effects of Aspirin and NHP-544C

CompletedNCT02189122

Vanderbilt UniversityHealthy

Start: 2014-07-31End: 2015-07-31Updated: 2016-07-12

Aspirin for Prevention of Preeclampsia

Aswan University HospitalPreeclampsia

Start: 2018-12-01End: 2021-01-01Target: 600Updated: 2019-01-10

Aspirin for Prevention of Preeclampsia in Healthy, Nulliparous Obese and Overweight Pregnant Women

Aswan University HospitalPreeclampsia

Start: 2018-12-01End: 2022-01-01Target: 600Updated: 2019-01-10